Genetic correction of sickle cell disease: Insights using transgenic mouse models
- 1 February 2000
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 6 (2) , 177-182
- https://doi.org/10.1038/72279
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Transgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell DiseaseScience, 1997
- Knockout-Transgenic Mouse Model of Sickle Cell DiseaseScience, 1997
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- The transgenic SAD mouse: A model of human sickle cell glomerulopathyKidney International, 1994
- Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.Journal of Clinical Investigation, 1994
- Developmental regulation of human gamma-globin genes in transgenic mice.Molecular and Cellular Biology, 1993
- A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin DisordersNew England Journal of Medicine, 1993
- A transgenic mouse model of sickle cell disorderNature, 1990
- The human beta-globin locus activation region alters the developmental fate of a human fetal globin gene in transgenic mice.Proceedings of the National Academy of Sciences, 1989
- Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemiaJournal of Clinical Investigation, 1968